Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Apidel logo — Revolutionizing Therapeutics through Cutting-Edge Drug Deliv...

Apidel

Revolutionizing Therapeutics through Cutting-Edge Drug Delivery Solutions

Founded 2011 Series C Biotechnology, Pharmaceutical

General Information

Company Name Apidel
Founded Year 2011
Industries Biotechnology, Pharmaceutical
Funding Stage Series C
Social

Get notified when Apidel moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Apidel

Apidel, an early-stage Swiss pharmaceutical company established in 2011, is focused on revolutionizing therapeutics through cutting-edge drug delivery solutions. Founded by two University of Geneva researchers and an industry executive, Apidel specializes in proprietary drug delivery technologies that improve the efficacy, safety, and cost-effectiveness of therapeutic products, thereby enhancing patient adherence to treatments. Apidel's expertise lies in reformulating both new and established drugs to maximize their therapeutic potential, creating opportunities for new indications for existing drug molecules. With a growing portfolio of granted patents and patent applications, Apidel protects all drugs formulated using its proprietary technologies. The company collaborates with pharmaceutical partners and maintains an internal pipeline of products using approved pharmaceuticals, thereby reducing clinical and regulatory risks and expediting development. Notably, Apidel's Series C investment in February 2017 from Valley Road Capital demonstrates investor confidence in its innovative approach. Apidel's name, derived from API (Active Pharmaceutical Ingredient) Delivery, underscores its technical proficiency in pharmaceutical formulation and effective drug delivery using polymeric vehicles. With an extensive product pipeline and strategic partnerships, Apidel is poised to create significant value for shareholders and make a lasting impact in the biotechnology and pharmaceutical industries.

Taxonomy: Pharmaceuticals, Drug delivery, Therapeutics, Polymeric vehicles, Medical technology, Research and development, Patent portfolio, Clinical development, Regulatory compliance, Partnerships, Geneva, Swiss company, Early-stage startup, Proprietary technologies, University research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 1 •••• •••• 02 Feb 2017

Apidel Alternatives & Competitors

Apidel vs
Zerion Pharma
Zerion Pharma Denmark

Zerion Pharma is a pharmaceutical company transforming the landscape for formulation of poorly solub...

18 employees
Health and Wellness, Pharmaceutical
Apidel vs
Aquestive Therapeutics
Aquestive Therapeutics United States

A pharmaceutical company advancing medicines to solve patients’ problems with current standards of c...

Post Ipo Equity
142 employees
Pharmaceutical
Compare Apidel vs Aquestive Therapeutics
Apidel vs
iCeutica
iCeutica United States

iCeutica is a privately held pharmaceutical research and development company located in King of Prus...

Series Unknown
6 employees
Biotechnology, Health Care

FAQ About Apidel

Revolutionizing Therapeutics through Cutting-Edge Drug Delivery Solutions
Apidel was founded in 2011.
Apidel operates in the following industries: Biotechnology, Pharmaceutical.
Apidel has completed 1 funding round. The latest funding stage is Series C.
Top alternatives and competitors to Apidel include Zerion Pharma, Aquestive Therapeutics, iCeutica, Alitair Pharmaceuticals, SciTech Development, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Apidel and Zerion Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Apidel and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy